BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 31634779)

  • 21. Medical findings of nasopharyngeal carcinoma patients and anti-tumor benefits of formononetin.
    Ying K; Liu Y; Zhang C; Shangguan M
    Eur J Pharmacol; 2019 Oct; 861():172619. PubMed ID: 31430458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel Hsp90 inhibitor AT13387 induces senescence in EBV-positive nasopharyngeal carcinoma cells and suppresses tumor formation.
    Chan KC; Ting CM; Chan PS; Lo MC; Lo KW; Curry JE; Smyth T; Lee AW; Ng WT; Tsao GS; Wong RN; Lung ML; Mak NK
    Mol Cancer; 2013 Oct; 12(1):128. PubMed ID: 24156782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-Cancer Properties of Ginkgolic Acids in Human Nasopharyngeal Carcinoma CNE-2Z Cells via Inhibition of Heat Shock Protein 90.
    Li HM; Ma H; Sun X; Li B; Cao C; Dai Y; Zhu M; Wu CZ
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770993
    [No Abstract]   [Full Text] [Related]  

  • 24. Elevated HSP90 associates with expression of HIF-1α and p-AKT and is predictive of poor prognosis in nasopharyngeal carcinoma.
    Feng J; Xie G; Zhan Y; Lu J; Xu L; Fan S; Wang W
    Histopathology; 2019 Aug; 75(2):202-212. PubMed ID: 30882922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FM807, a curcumin analogue, shows potent antitumor effects in nasopharyngeal carcinoma cells by heat shock protein 90 inhibition.
    Ye M; Huang W; Wu WW; Liu Y; Ye SN; Xu JH
    Oncotarget; 2017 Feb; 8(9):15364-15376. PubMed ID: 28157708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and biological significances of heat shock protein 90 (Hsp90) in human nasopharyngeal carcinoma cells and anti-cancer effects of Hsp90 inhibitor.
    Liu F; Wang L; Yi S; Liu Q; Xu X; Su M
    Biomed Pharmacother; 2019 Dec; 120():109533. PubMed ID: 31634779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential use of heat shock protein 90 as a biomarker for the diagnosis of human diseases.
    Rivas-Macho A; Romeo MV; Rackles E; Olabarria G; Falcon-Perez JM; Berganza-Granda J; Cortajarena AL; Goñi-de-Cerio F
    Expert Rev Mol Diagn; 2023; 23(10):875-884. PubMed ID: 37577928
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.